短時間読み取りシーケンシング市場：技術、製品、ワークフロー、用途、エンドユーザー別-2025-2030年の世界予測

短時間読み取りシーケンシング市場は、2023年に58億1,000万米ドルと評価され、2024年には67億3,000万米ドルに達すると予測され、CAGR 15.98％で成長し、2030年には164億1,000万米ドルになると予測されています。

短時間読み取りシーケンシングは、短いDNA断片の塩基配列を決定するために使用されるハイスループット技術であり、ゲノミクス研究、個別化医療、バイオテクノロジーにおいて極めて重要です。ゲノムワイドな関連研究、シングルセルシーケンス、診断検査に不可欠であり、その手頃な価格、効率性、正確性が評価されています。主な用途には、遺伝子疾患診断、がんゲノム、農業バイオテクノロジーなどがあり、主なエンドユーザーは研究機関、診断ラボ、製薬会社です。同市場は、技術の進歩、シーケンスコストの低下、個別化医療への需要の高まりによって活況を呈しています。データ解析のためのバイオインフォマティクスやAIとの統合は、その有用性を高めています。しかし、ショートリードでは反復領域や複雑なゲノムアセンブリーに対応できないため、ロングリード技術のサポートがなければ精度や解釈に課題が生じるなどの限界があります。また、ゲノムデータのプライバシーに関する倫理的問題や規制の複雑さも、市場成長の課題となっています。ショートリードとロングリードを組み合わせたハイブリッドアプローチによるシーケンス精度の向上や、データ解釈のためのアルゴリズムの改善には、数多くの機会が眠っています。イノベーションはまた、ポータブルシーケンスデバイスの開発、クラウドベースのゲノムデータソリューションの拡大、幅広いヘルスケアアプリケーションのためのポイントオブケア診断へのシーケンスの統合にも焦点を当てることができます。この市場の特徴は、急速なイノベーション、競合との競争、マルチオミクスアプローチの統合です。企業は研究開発に投資して技術を改良し、データプライバシーに関する懸念に対処し、規制状況を効果的にナビゲートするために継続的な利害関係者の関与を提唱すべきです。また、AIやバイオインフォマティクス企業との戦略的パートナーシップは、データ処理能力、個別化医療の革新、未開拓市場への進出において優位に立つことができます。この分野が発展するにつれ、利害関係者は、現在の限界と新たなヘルスケアニーズの両方に対応する強化されたシーケンスソリューションを通じて価値を創造することに注力しなければなりません。

市場力学：急速に進化する短時間読み取りシーケンシング市場の主要市場インサイトを公開

短時間読み取りシーケンシング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 個別化医療とコンパニオン診断に対する需要の高まり
  • 臨床研究における未知の遺伝子変異の検出における低コストシーケンシングに起因する需要の増加
  • 腫瘍学、感染症、生殖スクリーニング、薬理ゲノミクスなどの応用分野からの需要の急増
• 市場抑制要因
  • 熟練した専門家の不足と高コスト
• 市場機会
  • ゲノムシーケンスのコスト削減のための継続的な開発
  • 遺伝子配列決定のための共同研究の増加
• 市場の課題
  • 新興国における必要なインフラの不足

ポーターのファイブフォース：短時間読み取りシーケンシング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：短時間読み取りシーケンシング市場における外部からの影響の把握

外部マクロ環境要因は、短時間読み取りシーケンシング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析短時間読み取りシーケンシング市場における競合情勢の把握

短時間読み取りシーケンシング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス短時間読み取りシーケンシング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、短時間読み取りシーケンシング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨短時間読み取りシーケンシング市場における成功への道筋を描く

短時間読み取りシーケンシング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 個別化医療とコンパニオン診断の需要の高まり
    • 臨床調査における未知の遺伝子変異の検出における低コストのシークエンシングによる需要の増加
    • 腫瘍学、感染症、生殖スクリーニング、薬理ゲノム学などの応用分野からの需要の急増
  • 抑制要因
    • 熟練した専門家の不足と高コスト
  • 機会
    • ゲノム配列解析のコストを削減するための継続的な開発
    • 遺伝子配列解析のための協力の拡大
  • 課題
    • 新興国における必要なインフラの不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 短時間読み取りシーケンシング市場：技術別

• 次世代シーケンシング
• サンガーシーケンス

第7章 短時間読み取りシーケンシング市場：製品別

• 消耗品
• 機器
• サービス

第8章 短時間読み取りシーケンシング市場：ワークフロー別

• データ分析
• 事前シーケンス
• シーケンシング

第9章 短時間読み取りシーケンシング市場：用途別

• アグリゲノミクスと法医学
• 臨床調査
• 消費者ゲノミクス
• HLAタイピングと免疫システムのモニタリング
• メタゲノミクス、疫学、医薬品開発
• 腫瘍学
• 生殖に関する健康

第10章 短時間読み取りシーケンシング市場：エンドユーザー別

• 学術調査
• 臨床調査
• 病院・クリニック
• 製薬およびバイオテクノロジー企業

第11章 南北アメリカの短時間読み取りシーケンシング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の短時間読み取りシーケンシング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの短時間読み取りシーケンシング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 10x Genomics, Inc.
• Agilent Technologies, Inc.
• Almac Group
• Azenta Life Sciences
• BGI Genomics Co., Ltd.
• Eurofins Genomics LLC
• F. Hoffmann La Roche AG
• General Electric Company
• Genexa AG
• GenScript Biotech Corporation
• Illumina, Inc.
• PerkinElmer, Inc.
• Qiagen N.V.
• Seven Bridges Genomics, Inc.
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. SHORT-READ SEQUENCING MARKET RESEARCH PROCESS
• FIGURE 2. SHORT-READ SEQUENCING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. SHORT-READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. SHORT-READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SHORT-READ SEQUENCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SHORT-READ SEQUENCING MARKET DYNAMICS
• TABLE 7. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY AGRIGENOMICS & FORENSICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CLINICAL INVESTIGATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HLA TYPING & IMMUNE SYSTEM MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY METAGENOMICS, EPIDEMIOLOGY & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL SHORT-READ SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 50. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES SHORT-READ SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 77. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. CHINA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 82. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 168. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. ITALY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 188. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. POLAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 193. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. QATAR SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM SHORT-READ SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. SHORT-READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 241. SHORT-READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

The Short-read Sequencing Market was valued at USD 5.81 billion in 2023, expected to reach USD 6.73 billion in 2024, and is projected to grow at a CAGR of 15.98%, to USD 16.41 billion by 2030.

Short-read sequencing is a high-throughput technology used to determine the sequence of short DNA fragments, pivotal in genomics research, personalized medicine, and biotechnology. It is indispensable for genome-wide association studies, single-cell sequencing, and diagnostic testing due to its affordability, efficiency, and accuracy. Key applications include genetic disorder diagnostics, cancer genomics, and agricultural biotechnology with major end-users being research institutions, diagnostic labs, and pharmaceutical companies. The market is buoyed by technological advancements, decreasing sequencing costs, and increasing demand for personalized medicine. Integration with bioinformatics and AI for data analysis enhances its utility. However, limitations include short reads' inability to span repetitive regions and complex genome assemblies, leading to challenges in accuracy and interpretation without the support of long-read technologies. The market growth is also challenged by ethical issues concerning genomic data privacy and regulatory complexities. Numerous opportunities lie in enhancing sequencing accuracy through hybrid approaches combining short and long reads or improving algorithms for data interpretation. Innovation can also focus on developing portable sequencing devices, expanding cloud-based genomic data solutions, and integrating sequencing into point-of-care diagnostics for broader healthcare applications. The market is characterized by rapid innovation, competitive collaboration, and integration of multi-omics approaches. Companies should invest in R&D to refine technologies, address data privacy concerns, and advocate for continuous stakeholder engagement to navigate regulatory landscapes effectively. Strategic partnerships with AI and bioinformatics firms can also provide an edge in data handling capabilities, personalized medicine innovations, and expansion into untapped markets. As the field evolves, stakeholders must focus on creating value through enhanced sequencing solutions that address both current limitations and emerging healthcare needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Short-read Sequencing Market

The Short-read Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising demand for personalized medicine and companion diagnostics
  • Increasing demand attributed to low-cost sequencing in detection of unknown genetic variants in clinical research
  • Surge in demand from application areas such as oncology, infectious disease, reproductive screening and pharmacogenomics
• Market Restraints
  • Shortage of skilled professionals and high cost
• Market Opportunities
  • Ongoing developments to decrease the cost of genome sequencing
  • Growing collaboration for genetic sequencing
• Market Challenges
  • Dearth of required infrastructure in emerging economies

Porter's Five Forces: A Strategic Tool for Navigating the Short-read Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Short-read Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Short-read Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Short-read Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Short-read Sequencing Market

A detailed market share analysis in the Short-read Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Short-read Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Short-read Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Short-read Sequencing Market

A strategic analysis of the Short-read Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Short-read Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Almac Group, Azenta Life Sciences, BGI Genomics Co., Ltd., Eurofins Genomics LLC, F. Hoffmann La Roche AG, General Electric Company, Genexa AG, GenScript Biotech Corporation, Illumina, Inc., PerkinElmer, Inc., Qiagen N.V., Seven Bridges Genomics, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Short-read Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Next-Generation Sequencing and Sanger Sequencing.
• Based on Product, market is studied across Consumables, Instruments, and Services.
• Based on Workflow, market is studied across Data Analysis, Pre-Sequencing, and Sequencing.
• Based on Application, market is studied across Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics, HLA Typing & Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Oncology, and Reproductive Health.
• Based on End-User, market is studied across Academic Research, Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for personalized medicine and companion diagnostics
    • 5.1.1.2. Increasing demand attributed to low-cost sequencing in detection of unknown genetic variants in clinical research
    • 5.1.1.3. Surge in demand from application areas such as oncology, infectious disease, reproductive screening and pharmacogenomics
  • 5.1.2. Restraints
    • 5.1.2.1. Shortage of skilled professionals and high cost
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing developments to decrease the cost of genome sequencing
    • 5.1.3.2. Growing collaboration for genetic sequencing
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of required infrastructure in emerging economies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Short-read Sequencing Market, by Technology

• 6.1. Introduction
• 6.2. Next-Generation Sequencing
• 6.3. Sanger Sequencing

7. Short-read Sequencing Market, by Product

• 7.1. Introduction
• 7.2. Consumables
• 7.3. Instruments
• 7.4. Services

8. Short-read Sequencing Market, by Workflow

• 8.1. Introduction
• 8.2. Data Analysis
• 8.3. Pre-Sequencing
• 8.4. Sequencing

9. Short-read Sequencing Market, by Application

• 9.1. Introduction
• 9.2. Agrigenomics & Forensics
• 9.3. Clinical Investigation
• 9.4. Consumer Genomics
• 9.5. HLA Typing & Immune System Monitoring
• 9.6. Metagenomics, Epidemiology & Drug Development
• 9.7. Oncology
• 9.8. Reproductive Health

10. Short-read Sequencing Market, by End-User

• 10.1. Introduction
• 10.2. Academic Research
• 10.3. Clinical Research
• 10.4. Hospitals & Clinics
• 10.5. Pharma & Biotech Entities

11. Americas Short-read Sequencing Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Short-read Sequencing Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Short-read Sequencing Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. Agilent Technologies, Inc.
• 3. Almac Group
• 4. Azenta Life Sciences
• 5. BGI Genomics Co., Ltd.
• 6. Eurofins Genomics LLC
• 7. F. Hoffmann La Roche AG
• 8. General Electric Company
• 9. Genexa AG
• 10. GenScript Biotech Corporation
• 11. Illumina, Inc.
• 12. PerkinElmer, Inc.
• 13. Qiagen N.V.
• 14. Seven Bridges Genomics, Inc.
• 15. Thermo Fisher Scientific Inc.